Novo Nordisk downgrades sales outlook again amid bidding war with Pfizer for Metsera
Management lowers full-year guidance, warns about competition, launches bid for Metsera.
0 Comments
Related News
-
As bubble debate rages, a new study finds why companies are…
Nov 05, 2025 MarketWatch
-
Social Security survivor benefits from my late husband are …
Nov 05, 2025 MarketWatch
-
I invested $200K in my daughter’s 529 plan. She doesn’t wan…
Nov 05, 2025 MarketWatch
-
‘It’s survival math every month’: The rent crisis that got …
Nov 05, 2025 MarketWatch
-
Here’s how Pinterest’s holiday quarter just became a worry …
Nov 05, 2025 MarketWatch
Comments 0
No comments yet. Be the first to comment!